Wnt and the Wnt signaling pathway in bone development and disease

被引:191
作者
Wang, Yiping [1 ,2 ]
Li, Yi-Ping [1 ]
Paulson, Christie [1 ]
Shao, Jian-Zhong [2 ]
Zhang, Xiaoling [3 ,4 ]
Wu, Mengrui [1 ,2 ]
Chen, Wei [1 ]
机构
[1] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA
[2] Zhejiang Univ, Life Sci Coll, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China
[3] Chinese Acad Sci, SIBS, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai 200025, Peoples R China
[4] SJTUSM, Shanghai 200025, Peoples R China
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2014年 / 19卷
基金
美国国家卫生研究院;
关键词
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME; FRIZZLED-RELATED PROTEIN-1; SPLIT-HAND/FOOT MALFORMATION; RECEPTOR-RELATED PROTEIN-5; FOCAL DERMAL HYPOPLASIA; REGULATES CHONDROCYTE MATURATION; HOMOZYGOUS MISSENSE MUTATION; EMBRYONIC AXIS FORMATION; APICAL ECTODERMAL RIDGE; BETA-CATENIN STABILITY;
D O I
10.2741/4214
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Wnt signaling affects both bone modeling, which occurs during development, and bone remodeling, which is a lifelong process involving tissue renewal. Wnt signals are especially known to affect the differentiation of osteoblasts. In this review, we summarize recent advances in understanding the mechanisms of Wnt signaling, which is divided into two major branches: the canonical pathway and the noncanonical pathway. The canonical pathway is also called the Wnt/beta-catenin pathway. There are two major noncanonical pathways: the Wnt-planar cell polarity pathway (Wnt-PCP pathway) and the Wnt-calcium pathway (Wnt-Ca2+ pathway). This review also discusses how Wnt ligands, receptors, intracellular effectors, transcription factors, and antagonists affect both the bone modeling and bone remodeling processes. We also review the role of Wnt ligands, receptors, intracellular effectors, transcription factors, and antagonists in bone as demonstrated in mouse models. Disrupted Wnt signaling is linked to several bone diseases, including osteoporosis, van Buchem disease, and sclerosteosis. Studying the mechanism of Wnt signaling and its interactions with other signaling pathways in bone will provide potential therapeutic targets to treat these bone diseases.
引用
收藏
页码:379 / 407
页数:29
相关论文
共 292 条
  • [11] Axin-mediated CKI phosphorylation of β-catenin at Ser 45:: a molecular switch for the Wnt pathway
    Amit, S
    Hatzubai, A
    Birman, Y
    Andersen, JS
    Ben-Shushan, E
    Mann, M
    Ben-Neriah, Y
    Alkalay, I
    [J]. GENES & DEVELOPMENT, 2002, 16 (09) : 1066 - 1076
  • [12] High bone mass in mice expressing a mutant LRP5 gene
    Babij, P
    Zhao, WG
    Small, C
    Kharode, Y
    Yaworsky, PJ
    Bouxsein, ML
    Reddy, PS
    Bodine, PVN
    Robinson, JA
    Bhat, B
    Marzolf, J
    Moran, RA
    Bex, F
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (06) : 960 - 974
  • [13] Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow
    Bafico, A
    Liu, GZ
    Yaniv, A
    Gazit, A
    Aaronson, SA
    [J]. NATURE CELL BIOLOGY, 2001, 3 (07) : 683 - 686
  • [14] A generalized skeletal hyperostosis in two siblings caused by a novel mutation in the SOST gene
    Balemans, W
    Cleiren, E
    Siebers, U
    Horst, J
    Van Hul, W
    [J]. BONE, 2005, 36 (06) : 943 - 947
  • [15] Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease
    Balemans, W
    Patel, N
    Ebeling, M
    Van Hul, E
    Wuyts, W
    Lacza, C
    Dioszegi, M
    Dikkers, FG
    Hildering, P
    Willems, PJ
    Verheij, JBGM
    Lindpaintner, K
    Vickery, B
    Foernzler, D
    Van Hul, W
    [J]. JOURNAL OF MEDICAL GENETICS, 2002, 39 (02) : 91 - 97
  • [16] Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
    Balemans, W
    Ebeling, M
    Patel, N
    Van Hul, E
    Olson, P
    Dioszegi, M
    Lacza, C
    Wuyts, W
    Van den Ende, J
    Willems, P
    Paes-Alves, AF
    Hill, S
    Bueno, M
    Ramos, FJ
    Tacconi, P
    Dikkers, FG
    Stratakis, C
    Lindpaintner, K
    Vickery, B
    Foernzler, D
    Van Hul, W
    [J]. HUMAN MOLECULAR GENETICS, 2001, 10 (05) : 537 - 543
  • [17] The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations
    Balemans, Wendy
    Piters, Elke
    Cleiren, Erna
    Ai, Minrong
    Van Wesenbeeck, Liesbeth
    Warman, Matthew L.
    Van Hul, Wim
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2008, 82 (06) : 445 - 453
  • [18] Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells
    Bänziger, Carla
    Soldini, Davide
    Schuett, Corina
    Zipperlen, Peder
    Hausmann, George
    Basler, Konrad
    [J]. CELL, 2006, 125 (03) : 509 - 522
  • [19] WNT signaling in bone homeostasis and disease: from human mutations to treatments
    Baron, Roland
    Kneissel, Michaela
    [J]. NATURE MEDICINE, 2013, 19 (02) : 179 - 192
  • [20] Barros ER, 2008, J PEDIATR ENDOCR MET, V21, P811